+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Swine Epidemic Encephalitis Inactivated Vaccine Market by Animal Classification, Vaccine Type, Dosage Form, Packaging Size, End User, Distribution Channel - Global Forecast to 2030- Product Image
Swine Epidemic Encephalitis Inactivated Vaccine Market by Animal Classification, Vaccine Type, Dosage Form, Packaging Size, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Swine Epidemic Encephalitis Inactivated Vaccine Market by Animal Classification, Vaccine Type, Dosage Form, Packaging Size, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082031
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The market for swine epidemic encephalitis inactivated vaccines is undergoing significant transformation, fueled by regulatory changes, technological advancements, and shifting global trade dynamics. Senior decision-makers seeking to fortify their positions in the swine health sector will benefit from this detailed analysis, which highlights opportunities and challenges shaping vaccine development, manufacturing, and distribution across worldwide markets.

Market Snapshot: Swine Epidemic Encephalitis Inactivated Vaccine

The swine epidemic encephalitis inactivated vaccine market is experiencing defined growth as robust immunization becomes vital for global pork production. Advances in molecular biology are refining vaccine safety and immunogenicity, while blockchain and digital traceability tools enhance product integrity throughout the supply chain. Simultaneously, private-public collaborations are scaling up manufacturing to meet the needs of evolving pork trade requirements, especially amid stricter biosecurity standards in import and export markets. The deployment of artificial intelligence-driven predictive scheduling is improving on-farm vaccination strategies, ensuring producers achieve precise and effective disease control.

Scope & Segmentation

This report provides a granular breakdown of the swine epidemic encephalitis vaccine market, focusing on the interplay between product, user, and distribution variables across major regions and sub-regions.

  • Animal Classification: Boar, Grower Finisher Piglet, Suckling Piglet, Weaned Piglet, Gilt, Mature Sow
  • Vaccine Type: Attenuated Vaccine, Subunit Inactivated Vaccine, Whole Pathogen Inactivated Vaccine
  • Dosage Form: Liquid Suspension, Lyophilized Powder
  • Packaging Size: Multi Dose Vial, Single Dose Vial
  • End User: Commercial Swine Farm, Research Institution, Veterinary Clinic
  • Distribution Channel: Direct Sales, Distributors, Online Sales (E Commerce Platform, Manufacturer Website), Third Party Retailers
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with key markets such as United Kingdom, Germany, France, Russia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, Southeast Asia, among others)
  • Key Industry Players: Includes Hualan Biological Engineering Inc., Zoetis Inc., Boehringer Ingelheim Animal Health GmbH, Merck Animal Health, Ceva Santé Animale, and several leading regional manufacturers

Key Takeaways for Strategic Decision-Makers

  • Rising regulatory harmonization across major regions is streamlining approvals and accelerating time to market for next-generation inactivated vaccines.
  • Integration of digital tracking systems and blockchain technology is improving supply chain transparency and reducing risks related to counterfeit products.
  • Regional investment in local manufacturing capacity is increasing, as demand intensifies in markets undergoing rapid swine sector modernization and facing stringent import controls.
  • Customized dosing regimens targeting specific animal classifications—such as weaned piglets or gilts—are leading to differentiated, higher-value products in select markets.
  • Shift toward modular production lines and single-use technologies is enabling flexible scale-up and lean manufacturing, enhancing cost control and regulatory compliance.
  • The emergence of multi-channel distribution blends direct sales, digital platforms, and traditional retail, expanding market access and optimizing inventory flow.

Tariff Impact: Navigating the 2025 Regulatory Environment

The 2025 United States tariff adjustments have prompted significant realignment in both sourcing and manufacturing strategies. Higher duties on Asian-sourced raw materials are pushing manufacturers toward domestic suppliers, minimizing tariff exposure and protecting continuity of production. Increased levies on imported vaccines are incentivizing more formulation and fill-finish processes within national borders, but they are also elevating cost pressures—especially for smaller-scale end users. As a result, companies are forming long-term agreements and exploring partnerships to distribute tariff-related risk while accelerating adoption of efficiency-focused manufacturing solutions.

Methodology & Data Sources

This report employs a multi-layered approach, integrating quantitative data from industry surveys, executive interviews, and regulatory datasets with comprehensive secondary research. Primary insights from manufacturers, veterinarians, and biosecurity specialists are triangulated with trade records, patent filings, and public policy updates to validate findings. Expert panel peer reviews and outlier analyses ensure the reliability and actionable nature of every conclusion.

Why This Report Matters

  • Supports strategic planning by delivering a detailed view of market dynamics, regulatory trends, and emerging technologies in swine epidemic encephalitis inactivated vaccines.
  • Enables senior leaders to make informed R&D, supply chain, and go-to-market decisions, aligning with evolving trade and regulatory contexts.
  • Equips stakeholders with actionable segmentation insights, highlighting priority regions, product innovations, and channels for accelerated growth.

Conclusion

The swine epidemic encephalitis inactivated vaccine market is evolving rapidly in response to technological, regulatory, and trade-driven forces. Organizations that invest in advanced manufacturing, embrace digital distribution, and forge resilient partnerships will position themselves for sustained competitiveness and improved animal health outcomes.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Swine Epidemic Encephalitis Inactivated Vaccine Market, by Animal Classification
8.1. Introduction
8.2. Boar
8.3. Piglet
8.3.1. Grower Finisher Piglet
8.3.2. Suckling Piglet
8.3.3. Weaned Piglet
8.4. Sow
8.4.1. Gilt
8.4.2. Mature Sow
9. Swine Epidemic Encephalitis Inactivated Vaccine Market, by Vaccine Type
9.1. Introduction
9.2. Attenuated Vaccine
9.3. Inactivated Vaccine
9.3.1. Subunit Inactivated
9.3.2. Whole Pathogen Inactivated
10. Swine Epidemic Encephalitis Inactivated Vaccine Market, by Dosage Form
10.1. Introduction
10.2. Liquid Suspension
10.3. Lyophilized Powder
11. Swine Epidemic Encephalitis Inactivated Vaccine Market, by Packaging Size
11.1. Introduction
11.2. Multi Dose Vial
11.3. Single Dose Vial
12. Swine Epidemic Encephalitis Inactivated Vaccine Market, by End User
12.1. Introduction
12.2. Commercial Swine Farm
12.3. Research Institution
12.4. Veterinary Clinic
13. Swine Epidemic Encephalitis Inactivated Vaccine Market, by Distribution Channel
13.1. Introduction
13.2. Direct Sales
13.3. Distributors
13.4. Online Sales
13.4.1. E Commerce Platform
13.4.2. Manufacturer Website
13.5. Third Party Retailers
14. Americas Swine Epidemic Encephalitis Inactivated Vaccine Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Swine Epidemic Encephalitis Inactivated Vaccine Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Swine Epidemic Encephalitis Inactivated Vaccine Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Hualan Biological Engineering Inc.
17.3.2. Harbin Weitong Biological Product Co., Ltd.
17.3.3. Liaoning Chengda Biological Co., Ltd.
17.3.4. Shandong YEBIO Bioengineering Co., Ltd.
17.3.5. Anhui Dahuanong Biotechnology Co., Ltd.
17.3.6. Boehringer Ingelheim Animal Health GmbH
17.3.7. Ceva Santé Animale (International) S.A.
17.3.8. Zoetis Inc.
17.3.9. Merck & Co., Inc., d/b/a Merck Animal Health
17.3.10. Elanco Animal Health Incorporated
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET MULTI-CURRENCY
FIGURE 2. SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET MULTI-LANGUAGE
FIGURE 3. SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY BOAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY GROWER FINISHER PIGLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SUCKLING PIGLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY WEANED PIGLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY GILT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY MATURE SOW, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ATTENUATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SUBUNIT INACTIVATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY WHOLE PATHOGEN INACTIVATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY LIQUID SUSPENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY MULTI DOSE VIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SINGLE DOSE VIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COMMERCIAL SWINE FARM, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY RESEARCH INSTITUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VETERINARY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY E COMMERCE PLATFORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY THIRD PARTY RETAILERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 63. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 64. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 65. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 66. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 68. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 69. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 70. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 73. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 74. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 75. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 76. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 77. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 78. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 79. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 80. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 124. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 125. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 126. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 127. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 129. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 130. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 131. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 134. FRANCE SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 135. FRANCE SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 136. FRANCE SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 137. FRANCE SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 138. FRANCE SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 139. FRANCE SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 140. FRANCE SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 141. FRANCE SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. FRANCE SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. FRANCE SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 154. ITALY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 155. ITALY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 156. ITALY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 157. ITALY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 158. ITALY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 159. ITALY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 160. ITALY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 161. ITALY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. ITALY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. ITALY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 164. SPAIN SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 165. SPAIN SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 166. SPAIN SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 167. SPAIN SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 168. SPAIN SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 169. SPAIN SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 170. SPAIN SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 171. SPAIN SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. SPAIN SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. SPAIN SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 204. DENMARK SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 205. DENMARK SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 206. DENMARK SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 207. DENMARK SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 208. DENMARK SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 209. DENMARK SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 210. DENMARK SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 211. DENMARK SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. DENMARK SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. DENMARK SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 215. NETHERLANDS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 216. NETHERLANDS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 224. QATAR SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 225. QATAR SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 226. QATAR SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 227. QATAR SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 228. QATAR SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 229. QATAR SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 230. QATAR SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 231. QATAR SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. QATAR SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. QATAR SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 234. FINLAND SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 235. FINLAND SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 236. FINLAND SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 237. FINLAND SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 238. FINLAND SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 239. FINLAND SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 240. FINLAND SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 241. FINLAND SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. FINLAND SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. FINLAND SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 244. SWEDEN SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 245. SWEDEN SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 246. SWEDEN SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 254. NIGERIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 255. NIGERIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2030 (USD MILLION)
TABLE 256. NIGERIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 264. EGYPT SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2030 (USD MILLION)
TABLE 265. EGYPT SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VAC

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Swine Epidemic Encephalitis Inactivated Vaccine market report include:
  • Hualan Biological Engineering Inc.
  • Harbin Weitong Biological Product Co., Ltd.
  • Liaoning Chengda Biological Co., Ltd.
  • Shandong YEBIO Bioengineering Co., Ltd.
  • Anhui Dahuanong Biotechnology Co., Ltd.
  • Boehringer Ingelheim Animal Health GmbH
  • Ceva Santé Animale (International) S.A.
  • Zoetis Inc.
  • Merck & Co., Inc., d/b/a Merck Animal Health
  • Elanco Animal Health Incorporated

Related Topics

Related Reports

Porcine Epidemic Diarrhea Vaccines Market Report 2025 - Product Image

Porcine Epidemic Diarrhea Vaccines Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Swine Flu Vaccination Market Report 2025 - Product Image

Swine Flu Vaccination Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Porcine Vaccines Market by Vaccine Type (Inactivated, Live Attenuated, MRNA), Disease Indication (Classical Swine Fever, Erysipelas, Porcine Reproductive and Respiratory Syndrome), End User, Route Of Administration, Technology, Dosage Form - Global Forecast 2025-2030 - Product Image

Porcine Vaccines Market by Vaccine Type (Inactivated, Live Attenuated, MRNA), Disease Indication (Classical Swine Fever, Erysipelas, Porcine Reproductive and Respiratory Syndrome), End User, Route Of Administration, Technology, Dosage Form - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Porcine Vaccines - Global Strategic Business Report - Product Image

Porcine Vaccines - Global Strategic Business Report

  • Report
  • 376 Pages
  • Global
From
Inactivated Vaccines - Global Strategic Business Report - Product Image

Inactivated Vaccines - Global Strategic Business Report

  • Report
  • 468 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.